|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2878 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/75 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3768711 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19714024.7 |
| Europos patento paraiškos padavimo data | 2019-03-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/022391 |
| Data | 2019-03-15 |
| (87) | Numeris | WO 2019/182878 |
| Data | 2019-09-26 |
| (30) | Numeris | Data | Šalis |
| 201862647016 P | 2018-03-23 | US |
| (72) |
CARPENITO, Carmine , US
LI, Yiwen , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES |
| ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES |